Table 2

AuthorDrugNumber of casesBenefit

Thijs et al., 2010 [12]Temsirolimus1PFS 40 weeks
Lopez-Gonzales, 2011 [13]Cisplatin-Campto trabectedin1PDPFS 8 months
Chao, 2010Imatinib mesylate2PFS 0.2 and 1.1 months
Mrabti et al., 2011 [14]Anthracyclin1
Outc’s observatory ASCO 2010 #10097Sunitinib2PFS 2 and 6 months
Outc’s observatory ASCO 2010 #10097Sorafenib2PFS 3 months: stop at 3 months for toxicity